{"pub": "marketwatch", "url": "https://marketwatch.com/story/abbott-labs-gets-authorization-for-3-billion-in-additional-buybacks-2019-10-15", "downloaded_at": "2019-10-15 12:53:58.289304+00:00", "title": "Abbott Labs gets authorization for $3 billion in additional buybacks", "language": "en", "text": "Abbott Laboratories Inc. ABT, +0.24% said in a Tuesday filing that its board had authorized an additional $3 billion in share repurchases. The company said there is still a $795 million unused portion of its prior buyback program, which received approval in September 2014. Also on Tuesday, Abbott Labs announced that it would partner with Tandem Diabetes Care TNDM, +0.14% on diabetes-management options. Abbott Labs shares are up 0.9% in premarket trading Tuesday. The stock has risen 10% so far this year, as the S&P 500 SPX, -0.14% has gained 18%.", "description": "Abbott Laboratories Inc. said in a Tuesday filing that its board had authorized an additional $3 billion in share repurchases. The company said there is...", "authors": ["Emily Bary"], "top_image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "published_at": "2019-10-15"}